Nanolek LLC   Report issue

For profit Phase 3
Founded: Moscow Russian Federation (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2013
NCT02268045
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now